Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-016167
Filing Date
2009-07-09
Accepted
2009-07-09 16:39:52
Documents
1
Period of Report
2009-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4353
  Complete submission text file 0001140361-09-016167.txt   6278
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 509 MADISON AVE 14TH FL NEW YORK NY 10022
Business Address
KUO JAMES S (Reporting) CIK: 0001050951 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 09937493